Skip to main content
. Author manuscript; available in PMC: 2013 Aug 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):503–510. doi: 10.1097/QAI.0b013e318256b4f8

Table 1.

Summary of 4 surveillance studies conducted at Chris Hani Baragwanath Hospital 1996–2011

Period PMTCT available Wards
included		 Duration Sample
size		 Season Prospective Age of
children		 Age at diagnosis
of HIV ELISA vs.
DNA PCR
1 July–31 Dec 199614 None One of four 6 months 549 Winter-summer Yes < 5years 15 months
18 April–15 May 200513 CD4 <200 → ART start mother
CD4 > 200→ Single dose nevirapine for mother and baby		 All four 1 month 575 Autumn Yes <15 years 15 months
1 Oct–31 Dec 200712 CD4 <200 → ART start mother
CD4 >200→ Single dose nevirapine for mother and baby		 All four 3 months 1510 Spring-summer No <15 years 18 months
1 Aug 2010–31 Jan 2011 CD4<350 → ART start mother
CD4>350 → AZT from 14 weeks and single dose nevirapine for mother and baby		 One of four 6 months 429 Winter-summer Yes <15 years 18 months